Autoantibodies in Breast Cancer Detection

TerminatedOBSERVATIONAL
Enrollment

1,279

Participants

Timeline

Start Date

July 24, 2018

Primary Completion Date

March 11, 2024

Study Completion Date

March 11, 2024

Conditions
Breast Cancer
Interventions
OTHER

Collection of blood

Collection of blood only to look at circulating autoantibodies that recognize breast cancer proteins to potentially be used as a biosensor for identifying patients with increased risk of having breast cancer

Trial Locations (2)

57104

Sanford Health, Sioux Falls

58104

Sanford Health, Fargo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Inanovate

UNKNOWN

lead

Sanford Health

OTHER